![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/30 | |
C07K 16/32 | |||
C12N 15/13 | |||
C12N 15/63 | |||
A61K 39/395 | |||
A61P 35/00 | |||
G01N 33/53 |
(11) | Number of the document | 3115377 |
(13) | Kind of document | T |
(96) | European patent application number | 15879721.7 |
Date of filing the European patent application | 2015-12-08 | |
(97) | Date of publication of the European application | 2017-01-11 |
(45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2015/096674 |
Date | 2015-12-08 |
(87) | Number | WO 2016/119523 |
Date | 2016-08-04 |
(30) | Number | Date | Country code |
201510051280 | 2015-01-30 | CN |
(72) |
ZHOU, Qing, CN
SHU, Mengjun, CN
HE, Zhuzi, CN
LIN, Jun, CN
|
(73) |
Genor Biopharma Co., Ltd,
1690 Zhangheng Road Building 3 Floor 1-4 Zhangjiang Pudong, Shanghai 201203,
CN
|
(54) | MUTANT ANTIBODY OF FULL HUMAN HER2 ANTIBODY, CODING GENE AND USE THEREOF |
MUTANT ANTIBODY OF FULL HUMAN HER2 ANTIBODY, CODING GENE AND USE THEREOF |